Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after neurosurgical ventriculitis

Infezioni in Medicina

Volumn 18, Issue 3, 2010, Pages 182-186

  Baiocchi, Marco ^a   Catena, Vincenzo ^a   Zago, Stefano ^a   Badolati, Luigi ^a   Baccarin, Monica ^a  

^a ULSS 3   (Italy)

Author keywords

Cerebral spinal fluid; Colistin; Intrathecal

Indexed keywords

AMIKACIN; AZTREONAM; CEPHALOSPORIN DERIVATIVE; COLISTIN; MEROPENEM; SULTAMICILLIN; VANCOMYCIN;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN VENTRICULITIS; CASE REPORT; CEREBROSPINAL FLUID SHUNTING; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; FEVER; GLASGOW COMA SCALE; HUMAN; HYPOXIA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MULTIDRUG RESISTANCE; PNEUMONIA; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRACHEOTOMY;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICULITIS; CEREBROSPINAL FLUID SHUNTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; HYDROCEPHALUS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 78049461404     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Blount J.P., Campbell J.A., Haines S.J. Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin. N. Am. 4, 633-656, 1993.
2. Faillace W.J. A no-touch technique protocol to diminish cerebrospinal fluid shunt infection. Surg. Neurol. 43, 344-350, 1995.
3. McClelland S. 3rd, Hall W.A. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin. Infect. Dis. 45, 55-59, 2007.
4. McGirt M.J., Zaas A., Fuchs H.E., George T.M., Kaye K., Sexton D.J. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin. Infect. Dis. 36, 858-862, 2003.
5. Kulkarni A.V., Drake J.M., Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J. Neurosurg. 94, 195-201, 2001. (Pubitemid 32799678)
6. Conen A., Walti L.N., Merlo A., Fluckiger U., Battegay M., Trampuz A. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11 year period. Clin. Infect. Dis. 47, 73-82, 2008.
7. Katragkou A., Roilides E. Successful treatment of multi drug-resistant Acinetobacter baumanni central nervous system infections with colistin. J. Clin. Microbiol. 43, 4916-4917, 2005.
8. Falagas M.T., Kasiakou S.K. Colistin: the revival of polimyxin for the management of multidrug resistant Gram Negative bacteria infections. Clin. Infect. Dis. 40, 1333-1341, 2005.
9. Li J., Coulthard K., Milne R. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J. Antimicrob. Chemother. 52, 987-992, 2003.
10. Li J., Turnidge J., Milne R., Nation R.L., Coulthard K. In vitro pharmacodynamics properties of colistin and colistin methasulphonate against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Antimicrob. Agents Chemother. 45, 1766-1770, 2001.
11. Jimenez-Mejias M.E., Pichardo-Gurrero C., Marquez-Rivas F.J., Martin-Lozano D., et al. Cerebrospinal fluid penetration and pharmacokinetics/pharmacodynamics parameters of intravenously administrated colistin in a case of multi drug-resistant Acinetobacter baumanni meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 21, 212-214, 2002.
12. Burgess D.S. Use of pharmacokinetics and pharmacodynamics to optimise antimicrobial treatment of Pseudomonas aeruginosa infection. Clin. Infect. Dis. 40, S99-104, 2005.
13. Harris A.D., Smith D., Johnson J., et al. Risk factor for Imipenem resistant Pseudomonas aeruginosa among hospitalised patients. Clin. Infect. Dis. 43, 340-345, 2002. (Pubitemid 34062234)
14. Vasen W., Desmery P. Intrathecal use of colistin. J. Med. Microbiol. 38, 35-23, 2000.
15. Quinn A.N. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann. Pharmacother. 39, 949-952, 2005.
16. Yagmur R., Esen F. Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome. Crit. Care 10, 428, 2006.
17. Tunkell A.R., Hartmann B., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39, 1267-1284, 2004.
18. Quinn A.L. Intrathecal colistin and sterilization of resistant pseudomonas aeruginosa shunt infection. Ann. Pharmacother. 39, 5, 949-952, 2004.
19. th European Congress of Clinical Microbiology and Infectious Diseases Copenhagen, Denmark, April 2-5, 2005, Abstract number: 1134-02-277.
20. Gump W., Walsh J. Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis. Case report and review of the literature. J. Neurosurg. 102, 5, 915-917, 2005.
21. Enfanto C.M., Shin S. Treatment with Intrathecal Colistin of a Resistant Extended-Spectrum [beta]- Lactamase-Producing Klebsiella pneumoniae in the Cerebrospinal Fluid. Infect. Dis. Clin. Pract. 15, 4, 274-277, 2007.
22. Ng J., Gosbell I.B., Kelly J.A., Boyle M.J., Ferguson J.K. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J. Antimicrob. Chemother. 58, 5, 1078-1081, 2006.
23. Oie S., Uematsu T., Sawa A., et al. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. J. Antimicrob. Chemother. 52, 911-914, 2003.